Bliss GVS Pharma Limited (BLISSGVS) — Announcement | 15 July 2026

StockFin.ai

Try Free

📢 Key Event
KMPs authorized to report material events to exchanges

💡 Investor Takeaway
Shareholders should monitor future disclosures through these contacts for timely regulatory updates affecting company transparency.

Bliss GVS Pharma disclosed authorized contacts for material event reporting to exchanges, listing three KMPs and a company secretary with contact details for regulatory disclosures. The filing specifies authorized personnel and their communication channels for timely exchange notifications.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BLISSGVS ✨ Ask AI About This

About Bliss GVS Pharma Limited (BLISSGVS)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹2,937.23 Cr P/E: 49.0

View full BLISSGVS stock details →

📡 Get AI alerts when BLISSGVS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BLISSGVS — Free

💡 Ask AI about this filing

"How does this affect BLISSGVS margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More BLISSGVS filings

See all BLISSGVS filings →

🔥 Also filed on 15 July 2026

GROWW Billionbrains Garage Ventures Limited Offer Document RELTD Ravindra Energy Limited Offer Document J&KBANK The Jammu & Kashmir Bank Limited Announcement RPEL Raghav Productivity Enhancers Limited Financial Results VIMTALABS Vimta Labs Limited Financial Results HSCL Himadri Speciality Chemical Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when BLISSGVS files new disclosures

Track BLISSGVS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BLISSGVS — Free

Free account · 2 AI queries/day